Free tool
Drug Trial Radar: Dermatology
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
2
Not yet recruiting, industry sponsors, Dermatology, Phase 3
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed223
2 trials
Showing 1 to 2, recently updated first.
- An Open Label Extension Safety Study to Evaluate SD-101 in Epidermolysis BullosaPivotal-lookingNot yet recruiting
Paradigm TherapeuticsIndustry
NCT07482813 · 80 participants (planned) · Start Nov 15, 2026 · Primary completion Sep 19, 2027
Drug: SD-101 Dermal Cream (6%) · For: Epidermolysis Bullosa (EB)
- 1% Clascoterone Cream for the Treatment Acne VulgarisPivotal-lookingNot yet recruiting
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.Industry
NCT07457294 · 692 participants (planned) · Start May 4, 2026 · Primary completion Aug 7, 2028
Drug: 1% Clascoterone Cream; Placebo · For: Acne Vulgaris
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.